Skip to main content
OpenTrials
Active, not recruiting

NCT Number: NCT07825090

Association of ICU Admission Time, Age Stratification, and Clinical Frailty Scale With 30-Day Mortality in Geriatric Oncology Patients

Geriatric oncology patients frequently require intensive care admission and are at increased risk of adverse outcomes due to advanced age, frailty, and critical illness. Delays in admission from the emergency department to the intensive care unit (ICU) may further contribute to poor prognosis. This retrospective cohort study aims to evaluate the association of ICU admission time, age stratification, and Clinical Frailty Scale (CFS) score with 30-day mortality among geriatric cancer patients admitted from the emergency department to the Anesthesiology and Reanimation Intensive Care Unit. Secondary objectives include assessing the relationship of these factors with intensive care unit length of stay, hospital length of stay, and in-hospital mortality. The findings may contribute to improved risk stratification and optimization of critical care management in geriatric oncology patients.

Active, not recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research Hospital

Yenimahalle, Ankara, 0620, Turkey (Türkiye)

About this study

Geriatric oncology patients admitted from the emergency department to the intensive care unit (ICU) represent a particularly vulnerable population with a high risk of mortality due to advanced age, malignancy-related immunosuppression, multiple comorbidities, and reduced physiological reserve. Limited ICU bed capacity and the increasing burden of critically ill patients have made appropriate triage and timely ICU admission increasingly important in this patient group.

Recent studies have demonstrated that delays in ICU admission from the emergency department (boarding time) are significantly associated with increased 30-day mortality. In particular, delays ranging from 5 to 12 hours have been shown to exhibit a dose-response relationship, with mortality risk increasing in parallel with prolonged waiting times. Similarly, studies conducted in critically ill oncology patients have identified delayed ICU admission and ICU triage decisions made during off-hours as independent predictors of 30-day mortality. These findings suggest that multidisciplinary ICU triage during regular working hours and a lower threshold for ICU admission in critically ill oncology patients may improve clinical outcomes.

Furthermore, prolonged emergency department boarding before ICU admission has consistently been associated with adverse clinical outcomes and increased mortality among critically ill patients. Therefore, minimizing delays in ICU admission may represent an important strategy for improving prognosis in this high-risk population.

Despite these observations, there remains a paucity of data evaluating the independent effects of boarding time, Clinical Frailty Scale (CFS) score, and age on 30-day mortality in geriatric oncology patients. Therefore, the primary objective of this study is to investigate the independent associations of emergency department boarding time, CFS score, and age with 30-day mortality among oncology patients aged 65 years and older admitted from the emergency department to the Anesthesiology and Reanimation Intensive Care Unit (ARICU).

Patients will be stratified into three age groups: 65-74 years, 75-84 years, and ≥85 years. This classification is expected to provide a more detailed assessment of the impact of age-related differences in biological and physiological reserve, as well as tolerance to oncological treatments, on clinical outcomes.

The relationships between boarding time, CFS score, age, and 30-day mortality will be analyzed using multivariable statistical models adjusted for potential confounding variables, including disease severity indices such as the Sequential Organ Failure Assessment (SOFA) score and/or Acute Physiology and Chronic Health Evaluation II (APACHE II) score, cancer type and stage, comorbidity burden, and organ support therapies.

The findings of this study are expected to contribute to the optimization of ICU admission processes, improve risk stratification, and enhance understanding of the prognostic importance of early intensive care intervention in geriatric oncology patients. In addition, the results may provide a scientific basis for the development of evidence-based ICU admission and patient selection criteria for this high-risk population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years
  • Diagnosis of solid or hematologic malignancy
  • Admission from the Emergency Department to the Anesthesiology and Reanimation Intensive Care Unit
  • ICU admission between January 1, 2026 and July 1, 2026

Exclusion criteria

  • Age < 65 years
  • Missing data regarding boarding time, Clinical Frailty Scale score, or 30-day mortality
  • Readmission to the ICU during the same hospitalization
  • Patients transferred from hospital wards or other ICUs

Treatment and study plan

observation

Other

Retrospective observational assessment of emergency department boarding time, Clinical Frailty Scale score, age stratification, and their association with 30-day mortality in geriatric oncology patients admitted to the Anesthesiology and Reanimation Intensive Care Unit.

Primary outcomes

  1. 30-Day All-Cause Mortality

    Time frame: 30 days

    All cause mortality within 30 days after admission to the Anesthesiology and Reanimation Intensive Care Unit

Secondary outcomes

  1. Emergency Department Boarding Time

    Time frame: At intensive care unit admission

    Time elapsed between emergency department admission and intensive care unit admission, calculated as the difference between the recorded admission times.

  2. Pre-Admission Clinical Frailty Scale (CFS) Score

    Time frame: Baseline, prior to the acute illness leading to intensive care unit admission

    Baseline frailty status prior to the acute illness leading to intensive care unit admission will be assessed using the Clinical Frailty Scale (CFS), ranging from 1 (very fit) to 9 (terminally ill), with higher scores indicating greater frailty. The association between the pre-admission CFS score and 30-day mortality will be evaluated.

  3. Clinical Frailty Scale Score According to Age Group

    Time frame: Baseline, prior to the acute illness leading to intensive care unit admission.

    Pre-admission Clinical Frailty Scale (CFS) scores will be compared across predefined age groups (65-74 years, 75-84 years, and ≥85 years). CFS ranges from 1 (very fit) to 9 (terminally ill), with higher scores indicating greater frailty.

  4. Intensive Care Unit Length of Stay

    Time frame: At intensive care unit discharge

    Duration of stay in the intensive care unit measured in days from ICU admission to ICU discharge.

  5. 30-Day All-cause Mortality According to Age Group

    Time frame: From the date of ICU admission until death from any cause, assessed up to 30 days

    30 day all-cause mortality will be compared across predefined age groups (65-74 years, 75-84 years, and ≥85 years)

Sponsors and collaborators

Lead sponsor

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Other

Registry information

Official study title

Association of Time to Intensive Care Unit Admission, Age Stratification, and Clinical Frailty Scale With 30-Day Mortality in Geriatric Oncology Patients Admitted From the Emergency Department to the Anesthesiology and Reanimation Intensive Care Unit

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 17, 2026
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.